Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Epstein

Showing results (81-90 of 1,383) with videos related to

Pageof 139
Sort By:
Cancer Informatics|December 17, 2009
Unblocking blockbusters: using boolean text-mining to optimise clinical trial design and timeline for novel anticancer drugsRichard J Epstein
BMJ (Clinical Research Ed.)|January 9, 2015
"By the way doctor, I've booked an African safari after my next chemo"Richard J Epstein
BMC Cancer|June 1, 2007
Adjuvant breast cancer chemotherapy during late-trimester pregnancy: not quite a standard of careRichard J Epstein
International Ophthalmology Clinics|January 1, 1991
Contact lenses for the correction of pediatric aphakiaR J Epstein
The Annals of Pharmacotherapy|June 5, 2008
Efficacy and safety of darusentan: a novel endothelin receptor antagonistBenjamin J Epstein
Oncogene|July 20, 1995
Preferential detection of catalytically inactive c-erbB-2 by antibodies to unphosphorylated peptides mimicking receptor tyrosine autophosphorylation sitesR J Epstein
The Journal of Biological Chemistry|July 10, 1970
Phosphoribosyltransferase activity during early mammalian developmentC J Epstein
Advances in Experimental Medicine and Biology|January 1, 1985
Werner's syndrome and aging: a reappraisalC J Epstein
The New England Journal of Medicine|February 10, 1972
Inactivation of the x-chromosomeC J Epstein
Cancer Treatment Reviews|March 1, 1988
The clinical biology of hormone-responsive breast cancerR J Epstein
Pageof 139

Showing results (81-90 of 1,383) with videos related to

Sort By:
Pageof 139
Cancer Informatics|December 17, 2009
Unblocking blockbusters: using boolean text-mining to optimise clinical trial design and timeline for novel anticancer drugsRichard J Epstein
BMJ (Clinical Research Ed.)|January 9, 2015
"By the way doctor, I've booked an African safari after my next chemo"Richard J Epstein
BMC Cancer|June 1, 2007
Adjuvant breast cancer chemotherapy during late-trimester pregnancy: not quite a standard of careRichard J Epstein
International Ophthalmology Clinics|January 1, 1991
Contact lenses for the correction of pediatric aphakiaR J Epstein
The Annals of Pharmacotherapy|June 5, 2008
Efficacy and safety of darusentan: a novel endothelin receptor antagonistBenjamin J Epstein
Oncogene|July 20, 1995
Preferential detection of catalytically inactive c-erbB-2 by antibodies to unphosphorylated peptides mimicking receptor tyrosine autophosphorylation sitesR J Epstein
The Journal of Biological Chemistry|July 10, 1970
Phosphoribosyltransferase activity during early mammalian developmentC J Epstein
Advances in Experimental Medicine and Biology|January 1, 1985
Werner's syndrome and aging: a reappraisalC J Epstein
The New England Journal of Medicine|February 10, 1972
Inactivation of the x-chromosomeC J Epstein
Cancer Treatment Reviews|March 1, 1988
The clinical biology of hormone-responsive breast cancerR J Epstein
Pageof 139